# TPSB2

## Overview
The TPSB2 gene encodes the enzyme tryptase beta 2, a serine protease primarily found in mast cells. This enzyme is a critical component of the immune system, involved in processes such as tissue remodeling, wound healing, and the regulation of inflammation and vascular permeability (Lyons2021Inherited; Douaiher2014Development). Tryptase beta 2 is stored in mast cell granules and released during immune responses, where it functions as a tetramer stabilized by heparin (Atiakshin2018Tryptase; Lyons2021Mast). The enzyme's activity is essential for recruiting immune cells and modulating chemokine and cytokine expression, contributing to both normal physiological functions and pathological conditions such as allergies and chronic inflammation (Atiakshin2018Tryptase; Douaiher2014Development). Variations in the TPSB2 gene can influence tryptase activity and have been implicated in conditions like hereditary alpha-tryptasemia, although the clinical significance of these variations remains an area of ongoing research (Ziaie2021Hereditary; Glover2021Clinical).

## Function
The TPSB2 gene encodes tryptase beta 2, a serine protease predominantly expressed in mast cells. This enzyme plays a significant role in various molecular processes, particularly in the immune response. Tryptase beta 2 is involved in the degradation of extracellular matrix components, which is crucial for tissue remodeling and wound healing (Douaiher2014Development). It also participates in the activation of protease-activated receptors, influencing processes such as inflammation and vascular permeability (Lyons2021Inherited).

In mast cells, tryptase beta 2 is stored in secretory granules and is released into the extracellular space through mechanisms like exocytosis and piecemeal degranulation (Atiakshin2018Tryptase). The enzyme functions as a tetramer, with its activation dependent on an acidic environment and heparin binding within the granules (Lyons2021Mast). This tetrameric form is the most biologically active and is stabilized by heparin or other proteoglycans (Atiakshin2018Tryptase).

Tryptase beta 2 also plays a role in recruiting immune cells, such as neutrophils, during inflammatory responses and influences the expression of chemokines and cytokines (Douaiher2014Development). These activities contribute to its involvement in both physiological and pathological processes, including allergic reactions and chronic inflammation (Atiakshin2018Tryptase).

## Clinical Significance
Mutations and alterations in the TPSB2 gene, which encodes beta-tryptase, have clinical significance in various conditions. Hereditary alpha-tryptasemia (HaT) is a genetic condition associated with increased tryptase levels, often due to duplications in tryptase genes, including TPSB2. While HaT is primarily linked to alpha-tryptase, some cases involve beta-tryptase duplications, complicating the diagnosis and understanding of the condition (Ziaie2021Hereditary; Chollet2022Hereditary).

Variations in the TPSB2 gene can influence tryptase genotypes and complicate the interpretation of tryptase levels, although they are not directly associated with increased baseline serum tryptase levels (Glover2021Clinical). These genetic variations may affect the formation of tryptase heterotetramers, which have unique activities and can modify clinical phenotypes, such as the severity of anaphylaxis and pain sensation (Glover2021Clinical).

The presence of extra beta-tryptase alleles has been observed in some individuals, but these do not correlate with significant clinical differences, suggesting that the clinical impact of TPSB2 variations may be limited or context-dependent (Chollet2022Hereditary). Overall, while TPSB2 mutations and duplications can influence tryptase activity and related symptoms, their direct clinical implications require further investigation.


## References


[1. (Lyons2021Inherited) Jonathan J. Lyons. Inherited and acquired determinants of serum tryptase levels in humans. Annals of Allergy, Asthma &amp; Immunology, 127(4):420–426, October 2021. URL: http://dx.doi.org/10.1016/j.anai.2021.06.019, doi:10.1016/j.anai.2021.06.019. This article has 27 citations.](https://doi.org/10.1016/j.anai.2021.06.019)

[2. (Lyons2021Mast) Jonathan J. Lyons and Tangsheng Yi. Mast cell tryptases in allergic inflammation and immediate hypersensitivity. Current Opinion in Immunology, 72:94–106, October 2021. URL: http://dx.doi.org/10.1016/j.coi.2021.04.001, doi:10.1016/j.coi.2021.04.001. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.coi.2021.04.001)

[3. (Chollet2022Hereditary) Madeleine B. Chollet and Cem Akin. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes. Journal of Allergy and Clinical Immunology, 149(2):728-735.e2, February 2022. URL: http://dx.doi.org/10.1016/j.jaci.2021.06.017, doi:10.1016/j.jaci.2021.06.017. This article has 48 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2021.06.017)

[4. (Ziaie2021Hereditary) Navid Ziaie and Shyam Joshi. Hereditary alpha-tryptasemia: a case series with various clinical presentations. Journal of Allergy and Clinical Immunology, 147(2):AB135, February 2021. URL: http://dx.doi.org/10.1016/j.jaci.2020.12.493, doi:10.1016/j.jaci.2020.12.493. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2020.12.493)

[5. (Glover2021Clinical) Sarah C. Glover, Melody C. Carter, Peter Korošec, Patrizia Bonadonna, Lawrence B. Schwartz, Joshua D. Milner, George H. Caughey, Dean D. Metcalfe, and Jonathan J. Lyons. Clinical relevance of inherited genetic differences in human tryptases. Annals of Allergy, Asthma &amp; Immunology, 127(6):638–647, December 2021. URL: http://dx.doi.org/10.1016/j.anai.2021.08.009, doi:10.1016/j.anai.2021.08.009. This article has 32 citations.](https://doi.org/10.1016/j.anai.2021.08.009)

[6. (Atiakshin2018Tryptase) Dmitri Atiakshin, Igor Buchwalow, Vera Samoilova, and Markus Tiemann. Tryptase as a polyfunctional component of mast cells. Histochemistry and Cell Biology, 149(5):461–477, March 2018. URL: http://dx.doi.org/10.1007/s00418-018-1659-8, doi:10.1007/s00418-018-1659-8. This article has 72 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00418-018-1659-8)

[7. (Douaiher2014Development) Jeffrey Douaiher, Julien Succar, Luca Lancerotto, Michael F. Gurish, Dennis P. Orgill, Matthew J. Hamilton, Steven A. Krilis, and Richard L. Stevens. Development of Mast Cells and Importance of Their Tryptase and Chymase Serine Proteases in Inflammation and Wound Healing, pages 211–252. Elsevier, 2014. URL: http://dx.doi.org/10.1016/B978-0-12-800267-4.00006-7, doi:10.1016/b978-0-12-800267-4.00006-7. This article has 213 citations.](https://doi.org/10.1016/B978-0-12-800267-4.00006-7)